Amphiphilic graft copolymers
US-9150674-B2 · Oct 6, 2015 · US
US10654979B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10654979-B2 |
| Application number | US-201816058366-A |
| Country | US |
| Kind code | B2 |
| Filing date | Aug 8, 2018 |
| Priority date | Aug 18, 2017 |
| Publication date | May 19, 2020 |
| Grant date | May 19, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Amphiphilic graft copolymers comprise a polypropylene backbone and polyoxyalkylene side-chains (PPMA-g-PEO-PPO). These copolymers are suitable as additives to base polymeric formulations for medical devices for improving bond strength, paintability, dyeability, and printablity.
Opening claim text (preview).
What is claimed is: 1. A medical device formed from a blend comprising: a base polymeric formulation comprising at least a polymer or co-polymer of propylene; and an additive comprising a polypropylene-poly(ethylene oxide)-poly(propylene oxide) amphiphilic graft copolymer (PPMA-g-PEO-PPO); the PPMA-g-PEO-PPO being present in the blend in an amount in the range of about 0.01 to about 5.0% by weight of the blend; wherein the PPMA-g-PEO-PPO is according to Formula (I): wherein Me is CH 3 ; the molar value of m is in the range from 5 to 25 mole percent; and the molar value of n is in the range from 75 to 95 mole percent; the molar value of x is in the range from >0 to 40 propylene oxide units; and the molar value of y is in the range from >0 to 80 ethylene oxide units, and wherein the medical device is in the form of tubing. 2. The medical device of claim 1 , wherein the base polymeric formulation comprises polypropylene, a polyethylene-polypropylene co-polymer, a polypropylene-containing thermoplastic elastomer (TPE), or combinations thereof. 3. The medical device of claim 1 , wherein the PPMA-g-PEO-PPO is a product of polymerization of a maleated polypropylene and a polymeramine having monoamine functionality. 4. The medical device of claim 1 , wherein the PPMA-g-PEO-PPO has a weight average molecular weight (Mw) in the range of about 5,000 to about 300,000 g/mol. 5. The medical device of claim 1 , wherein the PPMA-g-PEO-PPO has a molar ratio of EO:PO of 2:1 or greater. 6. The medical device of claim 1 , wherein the PPMA-g-PEO-PPO has a dispersity index in the range of 1.5 to 9.
Mixtures of macromolecular compounds · CPC title
Tube connectors; Tube couplings {(A61M39/02 takes precedence; connecting needles to syringes or hubs A61M5/34; connecting catheter tubes to hubs A61M25/0014)} · CPC title
Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor · CPC title
Catheters; Hollow probes (dilators A61M29/00; {peritoneal catheters A61M1/285; tracheal tubes A61M16/04; for drainage A61M27/00; for uterus, vagina or rectum A61M31/00} ; for measuring or testing A61B; {materials for catheters A61L29/00}) · CPC title
Homopolymers or copolymers of propene · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.